• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Huge Announcement coming at the Neuro National Meeting


<



No big announcement. The problem is zyprexa, cymbalta over the next 24 months will be gone. You can't loose that much money and act like everyone is going to be fine. There will be deep cuts in BIO Medicines. They know it. Key is keep everyone motivated and believing until the end. Cardio is a joke, msk is hanging on to forteo and these so called new products that are coing will not make up enough money to support the overhead.

Ricks already told you- small targeted sales forces with 3/4 less the people in bio medicines. I also heard Neuro Leadership blocked people from applyint to Diabetes roles. Good luck if you are in Neuro it will be the calm before the storm. Also extensions of existing products, the FDA is done with that game. Trouble will come

Good luck for the next 24 months. Get to Diabetes or oncology if you can. THey are going to have 5-7 Districts selling the new ALZ. diagnostic test. Also medicare/medicaid cuts the private payors are changing the game as well. Good LUCK!
 












The 'Kevork-ster' will be testing out his new FIPNet-Reallocation machine: A 3-chambered syringe pump which delivers in sequence doses of zyprexa, strattera and cymbalta. It is green, it runs on FIPNet garlic fumes and pflegm.
 




The 'Kevork-ster' will be testing out his new FIPNet-Reallocation machine: A 3-chambered syringe pump which delivers in sequence doses of zyprexa, strattera and cymbalta. It is green, it runs on FIPNet garlic fumes and pflegm.

We dub thee:CALLILLOPE...for it plays the sweetest music of all whilst administering its FIPNet duties.